The world of healthcare is entering in a revolution that is even more far-reaching that than brought about the emergence of antibiotics : the switch from the quantified self to the qualified self, which has arisen, at least in part, from the in-depth knowledge that we have today of our genome.
Therapies are becoming inscreasingly effective – but the cost is high, thus restructing accessibility tu treatments as well as limiting reimbursements from public and private inssurance. As such, prevention « naturally » becomes a major social health issue.
THE TERM "FIBROSIS" DESCRIBES THE DEVELOPMENT OF AN EXCESS OF FIBROUS CONJUNCTIVE TISSUE AS A REPARATIVE RESPONSE TO AN INFLAMMATION.
When fibrosis is produced in response to a wound, the term ‘‘scar’’ is used. The development of fibrosis can be observed in any organ in the human body. Fibrosis is the base of numerous serious diseases which make up a list of 30 long-term illnesses that require prolonged treatment as well as particularly costly therapy, and for which preventative medicine would be a reasonable solution.
This new generation of predictive tools to detemermine the evolution of fibrosis has a triple benefit :
For practitioners: guide and improve their clinical choices
For patients: improve their quality of life and their chances of survival
Social security : generally reduce healthcare costs.
